Which has higher valuation & earnings, WAT or BRKR?

Waters has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waters $3.17B 12.80 $642.63M $4.01 102.84 Bruker $3.50B 2.59 -$8.60M -$0.70 N/A

Is WAT or BRKR more profitable?

Waters has a net margin of 3.58% compared to Bruker's net margin of -2.35%. Bruker's return on equity of 12.47% beat Waters' return on equity. Company Net Margins Return on Equity Return on Assets Waters 3.58% 11.27% 6.73% Bruker -2.35% 12.47% 4.91%

Does the media favor WAT or BRKR?

In the previous week, Waters had 15 more articles in the media than Bruker. MarketBeat recorded 24 mentions for Waters and 9 mentions for Bruker. Bruker's average media sentiment score of 1.63 beat Waters' score of 1.39 indicating that Bruker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waters 18 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bruker 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has better valuation and earnings, TECH or WAT?

Waters has higher revenue and earnings than Bio-Techne. Bio-Techne is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bio-Techne $1.22B 9.32 $181.86M $1.15 62.89 Waters $3.17B 12.80 $642.63M $4.01 102.84

Is TECH or WAT more profitable?

Bio-Techne has a net margin of 14.97% compared to Waters' net margin of 3.58%. Bio-Techne's return on equity of 13.23% beat Waters' return on equity. Company Net Margins Return on Equity Return on Assets Bio-Techne 14.97% 13.23% 10.61% Waters 3.58% 11.27% 6.73%

Does the media refer more to TECH or WAT?

In the previous week, Waters had 9 more articles in the media than Bio-Techne. MarketBeat recorded 24 mentions for Waters and 15 mentions for Bio-Techne. Waters' average media sentiment score of 1.39 beat Bio-Techne's score of 1.20 indicating that Waters is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Techne 11 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waters 18 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, A or WAT?

Agilent Technologies has higher revenue and earnings than Waters. Agilent Technologies is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agilent Technologies $6.95B 6.47 $1.30B $4.98 31.98 Waters $3.17B 12.80 $642.63M $4.01 102.84

Does the media refer more to A or WAT?

In the previous week, Agilent Technologies had 4 more articles in the media than Waters. MarketBeat recorded 28 mentions for Agilent Technologies and 24 mentions for Waters. Waters' average media sentiment score of 1.39 beat Agilent Technologies' score of 1.36 indicating that Waters is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 22 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waters 18 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, DHR or WAT?

Danaher has higher revenue and earnings than Waters. Danaher is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Danaher $24.57B 6.28 $3.61B $5.63 38.97 Waters $3.17B 12.80 $642.63M $4.01 102.84

Is DHR or WAT more profitable?

Danaher has a net margin of 15.95% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Danaher's return on equity. Company Net Margins Return on Equity Return on Assets Danaher 15.95% 11.04% 6.81% Waters 3.58% 11.27% 6.73%

Does the media refer more to DHR or WAT?

In the previous week, Danaher had 86 more articles in the media than Waters. MarketBeat recorded 110 mentions for Danaher and 24 mentions for Waters. Danaher's average media sentiment score of 1.72 beat Waters' score of 1.39 indicating that Danaher is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Danaher 109 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Waters 18 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, WAT or IQV?

IQVIA has higher revenue and earnings than Waters. IQVIA is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waters $3.17B 12.80 $642.63M $4.01 102.84 IQVIA $16.31B 2.63 $1.36B $8.06 32.28

Is WAT or IQV more profitable?

IQVIA has a net margin of 8.10% compared to Waters' net margin of 3.58%. IQVIA's return on equity of 30.25% beat Waters' return on equity. Company Net Margins Return on Equity Return on Assets Waters 3.58% 11.27% 6.73% IQVIA 8.10% 30.25% 6.54%

Does the media refer more to WAT or IQV?

In the previous week, IQVIA had 7 more articles in the media than Waters. MarketBeat recorded 31 mentions for IQVIA and 24 mentions for Waters. IQVIA's average media sentiment score of 1.49 beat Waters' score of 1.39 indicating that IQVIA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waters 18 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IQVIA 27 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Waters (WAT) Competitors

$412.37 +7.68 (+1.90%)

As of 08/21/2026 03:58 PM Eastern

Compare

WAT vs. BRKR, TECH, A, DHR, and IQV

Should you buy Waters stock or one of its competitors? Waters's main competitors and comparable companies include Bruker (BRKR), Bio-Techne (TECH), Agilent Technologies (A), Danaher (DHR), and IQVIA (IQV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Waters compare to Bruker?

Waters (NYSE:WAT) and Bruker (NASDAQ:BRKR) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

Waters has higher earnings, but lower revenue than Bruker. Bruker is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waters	$3.17B	12.80	$642.63M	$4.01	102.84
Bruker	$3.50B	2.59	-$8.60M	-$0.70	N/A

Waters has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, Bruker has a beta of 1.28, suggesting that its share price is 28% more volatile than the broader market.

94.0% of Waters shares are held by institutional investors. Comparatively, 79.5% of Bruker shares are held by institutional investors. 0.3% of Waters shares are held by company insiders. Comparatively, 27.2% of Bruker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Waters presently has a consensus price target of $420.35, indicating a potential upside of 1.94%. Bruker has a consensus price target of $56.64, indicating a potential downside of 4.90%. Given Waters' stronger consensus rating and higher probable upside, research analysts plainly believe Waters is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waters	0 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.75
Bruker	2 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.57

In the previous week, Waters had 15 more articles in the media than Bruker. MarketBeat recorded 24 mentions for Waters and 9 mentions for Bruker. Bruker's average media sentiment score of 1.63 beat Waters' score of 1.39 indicating that Bruker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waters	18 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bruker	8 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Waters has a net margin of 3.58% compared to Bruker's net margin of -2.35%. Bruker's return on equity of 12.47% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waters	3.58%	11.27%	6.73%
Bruker	-2.35%	12.47%	4.91%

Summary

Waters beats Bruker on 12 of the 17 factors compared between the two stocks.

How does Waters compare to Bio-Techne?

Bio-Techne (NASDAQ:TECH) and Waters (NYSE:WAT) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment, risk and earnings.

Waters has higher revenue and earnings than Bio-Techne. Bio-Techne is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Techne	$1.22B	9.32	$181.86M	$1.15	62.89
Waters	$3.17B	12.80	$642.63M	$4.01	102.84

99.0% of Bio-Techne shares are held by institutional investors. Comparatively, 94.0% of Waters shares are held by institutional investors. 1.3% of Bio-Techne shares are held by company insiders. Comparatively, 0.3% of Waters shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Bio-Techne has a net margin of 14.97% compared to Waters' net margin of 3.58%. Bio-Techne's return on equity of 13.23% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Techne	14.97%	13.23%	10.61%
Waters	3.58%	11.27%	6.73%

Bio-Techne currently has a consensus price target of $68.92, suggesting a potential downside of 4.70%. Waters has a consensus price target of $420.35, suggesting a potential upside of 1.94%. Given Waters' stronger consensus rating and higher probable upside, analysts clearly believe Waters is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Techne	1 Sell rating(s)	14 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.06
Waters	0 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.75

Bio-Techne has a beta of 1.28, suggesting that its share price is 28% more volatile than the broader market. Comparatively, Waters has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market.

In the previous week, Waters had 9 more articles in the media than Bio-Techne. MarketBeat recorded 24 mentions for Waters and 15 mentions for Bio-Techne. Waters' average media sentiment score of 1.39 beat Bio-Techne's score of 1.20 indicating that Waters is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Techne	11 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Waters	18 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Waters beats Bio-Techne on 11 of the 17 factors compared between the two stocks.

How does Waters compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Waters (NYSE:WAT) are both large-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

In the previous week, Agilent Technologies had 4 more articles in the media than Waters. MarketBeat recorded 28 mentions for Agilent Technologies and 24 mentions for Waters. Waters' average media sentiment score of 1.39 beat Agilent Technologies' score of 1.36 indicating that Waters is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	22 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Waters	18 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Agilent Technologies has higher revenue and earnings than Waters. Agilent Technologies is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.95B	6.47	$1.30B	$4.98	31.98
Waters	$3.17B	12.80	$642.63M	$4.01	102.84

Agilent Technologies currently has a consensus target price of $160.24, suggesting a potential upside of 0.62%. Waters has a consensus target price of $420.35, suggesting a potential upside of 1.94%. Given Waters' higher probable upside, analysts clearly believe Waters is more favorable than Agilent Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	2.89
Waters	0 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.75

Agilent Technologies has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market. Comparatively, Waters has a beta of 1.19, meaning that its stock price is 19% more volatile than the broader market.

Agilent Technologies has a net margin of 19.55% compared to Waters' net margin of 3.58%. Agilent Technologies' return on equity of 24.33% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.55%	24.33%	12.99%
Waters	3.58%	11.27%	6.73%

94.0% of Waters shares are owned by institutional investors. 0.3% of Waters shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Agilent Technologies beats Waters on 10 of the 17 factors compared between the two stocks.

How does Waters compare to Danaher?

Danaher (NYSE:DHR) and Waters (NYSE:WAT) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

79.1% of Danaher shares are owned by institutional investors. Comparatively, 94.0% of Waters shares are owned by institutional investors. 10.8% of Danaher shares are owned by company insiders. Comparatively, 0.3% of Waters shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Danaher has a net margin of 15.95% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Danaher	15.95%	11.04%	6.81%
Waters	3.58%	11.27%	6.73%

Danaher has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market. Comparatively, Waters has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market.

Danaher has higher revenue and earnings than Waters. Danaher is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Danaher	$24.57B	6.28	$3.61B	$5.63	38.97
Waters	$3.17B	12.80	$642.63M	$4.01	102.84

In the previous week, Danaher had 86 more articles in the media than Waters. MarketBeat recorded 110 mentions for Danaher and 24 mentions for Waters. Danaher's average media sentiment score of 1.72 beat Waters' score of 1.39 indicating that Danaher is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Danaher	109 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Waters	18 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Danaher presently has a consensus price target of $228.91, suggesting a potential upside of 4.33%. Waters has a consensus price target of $420.35, suggesting a potential upside of 1.94%. Given Danaher's stronger consensus rating and higher possible upside, equities research analysts plainly believe Danaher is more favorable than Waters.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Danaher	0 Sell rating(s)	5 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.84
Waters	0 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.75

Summary

Danaher beats Waters on 11 of the 17 factors compared between the two stocks.

How does Waters compare to IQVIA?

Waters (NYSE:WAT) and IQVIA (NYSE:IQV) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability.

Waters has a beta of 1.19, indicating that its stock price is 19% more volatile than the broader market. Comparatively, IQVIA has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market.

IQVIA has a net margin of 8.10% compared to Waters' net margin of 3.58%. IQVIA's return on equity of 30.25% beat Waters' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waters	3.58%	11.27%	6.73%
IQVIA	8.10%	30.25%	6.54%

Waters currently has a consensus target price of $420.35, suggesting a potential upside of 1.94%. IQVIA has a consensus target price of $241.88, suggesting a potential downside of 7.03%. Given Waters' higher possible upside, equities research analysts plainly believe Waters is more favorable than IQVIA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waters	0 Sell rating(s)	8 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.75
IQVIA	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.88

IQVIA has higher revenue and earnings than Waters. IQVIA is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waters	$3.17B	12.80	$642.63M	$4.01	102.84
IQVIA	$16.31B	2.63	$1.36B	$8.06	32.28

In the previous week, IQVIA had 7 more articles in the media than Waters. MarketBeat recorded 31 mentions for IQVIA and 24 mentions for Waters. IQVIA's average media sentiment score of 1.49 beat Waters' score of 1.39 indicating that IQVIA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waters	18 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IQVIA	27 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

94.0% of Waters shares are owned by institutional investors. Comparatively, 89.6% of IQVIA shares are owned by institutional investors. 0.3% of Waters shares are owned by insiders. Comparatively, 1.7% of IQVIA shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

IQVIA beats Waters on 10 of the 17 factors compared between the two stocks.

Get Waters News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WAT vs. The Competition

Export

Metric	Waters	Life Sciences Tools & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$40.35B	$10.24B	$7.37B	$24.30B
Dividend Yield	N/A	1.45%	2.53%	3.70%
P/E Ratio	102.84	61.54	272.60	30.31
Price / Sales	12.80	110.99	624.33	19.95
Price / Cash	24.70	27.04	78.62	32.49
Price / Book	2.67	37.34	13.05	6.77
Net Income	$642.63M	$56.67B	$3.47B	$1.07B
7 Day Performance	0.12%	5.24%	2.09%	-0.65%
1 Month Performance	7.84%	9.02%	6.64%	3.38%
1 Year Performance	36.58%	24.45%	25.02%	14.90%

Waters Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WAT Waters	2.8296 of 5 stars	$412.37 +1.9%	$420.35 +1.9%	+36.6%	$40.35B	$3.17B	102.84	7,900
BRKR Bruker	3 of 5 stars	$57.67 -0.1%	$56.64 -1.8%	+67.6%	$8.79B	$3.44B	N/A	11,085	Dividend Announcement
TECH Bio-Techne	3.2183 of 5 stars	$72.39 0.0%	$68.92 -4.8%	+26.7%	$11.34B	$1.22B	62.95	3,100	News Coverage Positive News Analyst Forecast
A Agilent Technologies	4.5125 of 5 stars	$148.65 +0.1%	$160.24 +7.8%	+31.1%	$41.95B	$6.95B	29.85	18,100	News Coverage Positive News Upcoming Earnings
DHR Danaher	4.0261 of 5 stars	$202.44 0.0%	$228.91 +13.1%	+3.6%	$142.32B	$24.57B	35.96	60,000	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:WAT) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Waters (WAT) Competitors